Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

NULL
   
  • Closing Price Chg:
    -10.00p
  • 52 Week High: NUL
  • 52 Week Low: 918.00p
  • Currency: UK Pounds
  • Shares Issued: 875.96m
  • Volume: 0
  • RiskGrade: 173
  • Beta: 0.00

Smith and Nephew Overview

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. It operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Smith and Nephew Financials

Latest F'cast
Div Yield 2.4% 0.0%
Div Cover 2.2 2.6
Op Mrgn 11.3% 17.6%
ROCE 13.3%  
Latest F'cast
P/E 18.2 15.2
PEG 10.1 n/a
Pr/Revenue 2.3 1.7
Pr/Book 2.6  
Latest F'cast
Revenue 4.7% -20.4%
PBT 71.7% 63.8%
EPS 1.8% -8.7%
DPS n/a -39.8%

Smith and Nephew Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 4,560.00 246.00 64.60¢ 30.9 n/a -37% 37.50¢ 1.9%
31-Dec-21 5,212.00 586.00 80.90¢ 21.1 0.8 +25% 37.50¢ 2.2%
31-Dec-22 5,215.00 235.00 81.80¢ 17.9 17.9 +1% 37.50¢ 2.6%
31-Dec-23 5,549.00 290.00 82.80¢ 17.2 17.2 +1% 37.50¢ 2.6%
31-Dec-24 5,810.00 498.00 84.30¢ 15.5 7.8 +2% 37.50¢ 2.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Smith and Nephew Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 6,108.90 1,077.71 76.96p 15.1 n/a -9% 29.79p 0.0%
31-Dec-26 6,434.50 1,193.38 87.39p 13.3 1.0 +14% 32.70p 0.0%
31-Dec-27 6,755.66 1,314.79 91.08p 12.8 3.0 +4% 35.90p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Smith and Nephew Company Announcements

Notice of Results 21-Jul-2025 11:51 RNS
Director/PDMR Shareholding 11-Jul-2025 10:00 RNS
Total Voting Rights 01-Jul-2025 13:30 RNS

Smith and Nephew ShareCast News

Smith & Nephew appoints Ajay Dhankhar as chief c... 23-Jun-2025 ShareCast
Smith & Nephew secures US DOD contract worth up ... 27-May-2025 ShareCast
London close: Stocks finish higher as US economy... 30-Apr-2025 ShareCast

Smith and Nephew Top Newspaper Links

Festive cheer for Smith & Nephew as shares jump ... 26-Dec-2014 Daily Mail
Smith & Nephew shares jump 10pc on Stryker bid r... 26-Dec-2014 Telegraph
MARKET REPORT: Bid talk boosts Smith & Nephew 26-Nov-2014 Express & Star

Latest Smith and Nephew Director Deals

Traded Action Notifier PriceAmountValue
09-Jul-25 Buy Deepak Nath 2,191.14p 512 £11,218.61

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change -10.00p
% Change 0.00 %
52 Week High NUL
52 Week Low 918.00p
Volume 0
Shares Issued 875.96m
Beta 0.00
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.33% below the market average90.33% below the market average90.33% below the market average90.33% below the market average90.33% below the market average
9.68% above the sector average9.68% above the sector average9.68% above the sector average9.68% above the sector average9.68% above the sector average
Price Trend
33.55% above the market average33.55% above the market average33.55% above the market average33.55% above the market average33.55% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average
Income
51.96% below the market average51.96% below the market average51.96% below the market average51.96% below the market average51.96% below the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
12.53% above the market average12.53% above the market average12.53% above the market average12.53% above the market average12.53% above the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 9
Sell 0
Strong Sell 0
Total 16
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Final Interim
Ex-Div 27-Mar-25 03-Oct-24
Paid 28-May-25 08-Nov-24
Amount 23.10¢ 14.40¢

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Smith and Nephew Key Personnel

CEO Deepak Nath
CFO John Rogers

Top of Page